By: Rowan Walrath
Alterome Therapeutics will use the funds to get two drug candidates into human studies
Life Sciences Reporter, Boston Business Journal
Rowan Walrath is a life sciences reporter for the Boston Business Journal. With a focus on the biotechnology and pharmaceutical industries, Rowan covers a wide range of topics including drug approvals, gene therapies, medical device manufacturing, and healthcare conferences. Her work has also been featured in publications such as the Charlotte Business Journal, NBC Boston Stations, and Yahoo Finance.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
International
Rowan predominantly covers healthcare, pharmaceuticals, and biotechnology. She often reports on company announcements such as acquisitions, FDA approvals, IPO filings, and product developments in the life sciences industry.
To effectively pitch to Rowan Walrath consider offering exclusive insights or expert analysis related to new drug approvals by the FDA, significant mergers or acquisitions within the biotech sector, groundbreaking advancements in medical devices or gene therapy technologies. Additionally, if you are part of a company making major announcements in these areas it could be of interest to her.
While there is no specified geographic focus for Rowan's coverage area she appears to cover national and international news pertaining to healthcare and the pharmaceutical industry.
This information evolves through artificial intelligence and human feedback. Improve this profile .